Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Sees Large Decline in Short Interest

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) was the recipient of a large decline in short interest during the month of August. As of August 31st, there was short interest totalling 7,600 shares, a decline of 32.7% from the August 15th total of 11,300 shares. Based on an average daily trading volume, of 104,100 shares, the short-interest ratio is presently 0.1 days.

Ono Pharmaceutical Stock Up 0.5 %

Shares of Ono Pharmaceutical stock traded up $0.02 on Monday, reaching $4.45. The stock had a trading volume of 211,624 shares, compared to its average volume of 131,307. The company has a 50 day moving average price of $4.77 and a 200 day moving average price of $4.90. Ono Pharmaceutical has a 1 year low of $4.32 and a 1 year high of $6.69.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.